News | December 01, 2009

SNM’s Conjoint Mid-Winter Meetings Offer Four Scientific Meetings in One Location

November 23, 2009 — SNM will hold its Conjoint Mid-Winter Meetings on Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M.

This year, SNM joins its annual Mid-Winter Educational Symposium with the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM), the Nanomedicine and Molecular Imaging Summit and the Clinical Trials Network Community Workshop. The seven-day event offers participants a wide range of scientific content that covers nuclear medicine, molecular imaging, nanomedicine and clinical trials.

“The mid-winter meeting has grown to include more exceptional educational and scientific content,” said Michael M. Graham, Ph.D., M.D., president of SNM. “Attendees will find that they have more opportunities than ever before to earn educational credit, network with colleagues and learn from the top educators and innovators in the field.”

Leading molecular imaging and nuclear medicine physicians and scientists, radiologists, cardiologists, radiopharmacists and technologists representing the world’s top medical and academic institutions and centers will lead sessions. Attendees will have the opportunity to earn up to 25 continuing education credits.

The ACNM Annual Meeting and Educational Symposium, which begins on Jan. 27, will feature lectures about the use of PET/CT in the brain and neck, genitourinary system, head and neck cancer and thyroid cancer.

SNM’s Mid-Winter Educational Symposium, which begins on Jan. 30, will include numerous educational sessions, including the popular CT Case Review sessions, which include 100 cases and 16 credits. In a session titled, “The Sharp Edges of Nuclear Medicine: See What’s New,” technologists will be introduced to the newest techniques in fusion imaging and imaging with a focus on patients with epilepsy.

Peter Herscovitch, M.D., chair of SNM’s Scientific Program Committee, said, “We are very pleased about the quality of this year’s educational program, which offers top-notch scientific content from some of the leaders in the field of nuclear medicine and molecular imaging.”

SNM’s Nanomedicine and Molecular Imaging Summit, which takes place Jan. 31–Feb. 1, will provide a thought-provoking setting in which to examine key issues related to the rapid growth and evolving science of nanomedicine. The summit will delve into the cutting-edge field of nanotechnology, offering five sessions, followed by a roundtable and panel discussions.

The SNM Clinical Trials Network Community Workshop will provide hands-on training to physicians and technologists through the clinical research imaging technologist certification curriculum; multi-site imaging challenges for investigational therapeutics clinical trials; site qualification via the SNM Clinical Trials Network phantom program; multicenter clinical trials production; and site inspections.

“With expanded offerings and more days to fit in activities, SNM’s Conjoint Mid-Winter Meetings will certainly be a fulfilling event for all who attend,” said Graham.

For more information: www.snm.org/mwm.

Related Content

Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Overlay Init